Sanofi ADS - ADR Financials

$44.08

$-0.25 (-0.56%)

As on 04-Sep-2026 13:38EDT

Market cap

$107,395 Mln

Revenue (TTM)

$48,919 Mln

P/E Ratio

23.7

P/B Ratio

1.3

Div. Yield

9.2 %

Income Statement (€ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	48,919.00	46,716.00	44,286.00	41,618.00	40,561.00	39,175.00
Cost of Revenue	13,197.00	13,049.00	13,205.00	12,628.00	11,882.00	12,255.00
Gross Profit	35,722.00	33,667.00	31,081.00	28,990.00	28,679.00	26,920.00
Operating Expenses	28,484.00	24,070.00	23,829.00	22,030.00	18,517.00	18,794.00
Operating Profit (EBIT)	7,238.00	9,597.00	7,252.00	6,960.00	10,162.00	8,126.00
Other Income	--	--	--	--	--	--
Profit before Tax	5,195.00	6,020.00	6,758.00	6,115.00	9,992.00	7,837.00
Provision for Tax	1,203.00	1,043.00	1,204.00	1,017.00	1,909.00	1,558.00
Profit after Tax (Net Income)	3,958.00	7,813.00	5,560.00	5,400.00	8,371.00	6,223.00
Minority Interest	-53.00	-38.00	-58.00	-36.00	-113.00	-56.00
Consolidated Profit	--	--	--	--	8,371.00	6,223.00

Liabilities (€ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	69,207.00	71,376.00	77,507.00	74,040.00	74,784.00	68,681.00
Minority Interest	-53.00	--	--	--	--	--
Non-Current Liabilities	27,563.00	26,750.00	25,779.00	27,917.00	27,606.00	29,916.00
Current Liabilities	31,930.00	28,345.00	29,162.00	24,194.00	23,964.00	21,295.00
Total Liabilities	160,990.00	126,805.00	132,798.00	126,464.00	126,722.00	120,242.00

Assets (€ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	97,538.00	95,853.00	90,210.00	95,809.00	92,696.00	89,678.00
Current Assets	31,522.00	30,952.00	42,588.00	30,655.00	34,026.00	30,564.00
Total Assets	160,990.00	126,805.00	132,798.00	126,464.00	126,722.00	120,242.00
Total Debt*	23,576.00	20,329.00	17,906.00	18,697.00	21,212.00	22,414.00
Net Current Assets	-408.00	2,607.00	13,426.00	6,463.00	10,137.00	9,358.00

Cashflow (€ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	12,132.21	9,081.00	10,258.00	10,526.00	10,522.00
Cash Flow from Investing Activities	--	-2,761.63	-4,407.00	-6,200.00	-2,075.00	-7,298.00
Cash from Financing Activities	--	-9,262.24	-5,763.00	-8,052.00	-5,821.00	-7,056.00
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS (€)	1.62	3.20	2.22	2.15	3.34	2.48
Cash EPS (€)	--	5.53	3.65	4.07	4.16	3.11
Adjusted Book Value (€)	--	29.24	30.91	29.53	29.82	27.37
Dividend per Share (€)	--	--	--	--	--	--
Cash Flow per Share (€)	--	4.97	3.62	4.09	4.20	4.19
Free Cash Flow per Share (€)	--	4.16	2.35	2.93	3.32	3.38

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	8.35	5.91	5.72	8.95	7.00
ROE (%)	5.56	10.50	7.34	7.26	11.67	9.44
ROA (%)	2.51	6.02	4.29	4.27	6.78	5.30
EBIT Margin (%)	18.18	14.56	16.82	16.73	25.65	20.90
Net Margin (%)	8.09	16.72	12.55	12.98	20.64	15.89
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	13.42	0.05	0.06	0.03	0.04	0.05
EBIT Growth (%)	11.11	-8.67	6.98	-33.08	27.06	-42.39
Net Profit Growth (%)	-56.90	40.52	2.96	-35.49	34.52	-49.38
EPS Growth (%)	-55.93	0.44	0.03	-0.35	0.35	-0.49
Book Value Growth (%)	1.94	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	0.21	0.28	0.23	0.25	0.28	0.33
Short term debt to equity ratio	0.10	0.06	0.06	0.04	0.06	0.05
Current Ratio	0.99	1.09	1.46	1.27	1.42	1.44
Quick Ratio	0.23	0.73	1.14	0.87	1.05	1.03
Interest Coverage	9.78	10.86	11.96	13.57	27.03	21.69

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	18.82	23.65	24.00	26.53	26.49	24.98
Asset Turnover	0.31	0.36	0.34	0.33	0.33	0.33
Receivable days	--	84.73	89.36	95.60	92.45	92.02
Inventory Days	--	274.94	264.11	269.37	271.66	254.33
Payable days	--	208.70	205.78	204.51	199.70	171.00
Cash Conversion Cycle	--	150.97	147.69	160.46	164.41	175.36

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (€ Mln)